Neoadjuvant chemotherapy in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Axilla Esophagogastric Junction Lymph Nodes Extremities Breast Ureter Cell Line, Tumor Urothelium Microvessels

Diseases59

Breast Neoplasms Osteosarcoma Neoplasm Recurrence, Local Neoplasm, Residual Carcinoma, Ductal, Breast Lymphatic Metastasis Carcinoma, Lobular Adenocarcinoma Esophageal Neoplasms Bone Neoplasms Rectal Neoplasms Muscle Neoplasms Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma Stomach Neoplasms Lung Neoplasms Nasopharyngeal Neoplasms Carcinoma, Transitional Cell Sarcoma Neoplasm Invasiveness Ureteral Neoplasms Ovarian Neoplasms Uterine Cervical Neoplasms Liver Neoplasms Colorectal Neoplasms Head and Neck Neoplasms Neoplasm Metastasis Femoral Neoplasms Hydrophthalmos Nausea Carcinoma, Non-Small-Cell Lung Hepatoblastoma Neutropenia Carcinoma, Ductal Vomiting Histiocytoma, Benign Fibrous Leukopenia Disease Progression Pancreatic Neoplasms Soft Tissue Neoplasms Recurrence Adenocarcinoma, Scirrhous Neoplasm Micrometastasis Neoplasms, Glandular and Epithelial Sarcoma, Ewing Pleural Neoplasms Neoplasms, Hormone-Dependent Neoplasms Surgical Wound Dehiscence Urologic Neoplasms Testicular Neoplasms Peritoneal Neoplasms Postoperative Complications Prostatic Neoplasms Lymphoma, Non-Hodgkin Hodgkin Disease Brain Neoplasms Retroperitoneal Neoplasms

Chemicals and Drugs60

Doxorubicin Cisplatin Taxoids Cyclophosphamide Epirubicin Anthracyclines Fluorouracil Antineoplastic Agents Paclitaxel Receptor, erbB-2 Bridged Compounds Biomarkers, Pharmacological Methotrexate Receptors, Estrogen Vinblastine Deoxycytidine Receptors, Progesterone Tumor Markers, Biological Ifosfamide Carboplatin Fluorodeoxyglucose F18 Organoplatinum Compounds Antibodies, Monoclonal, Humanized Etoposide Ki-67 Antigen Radiopharmaceuticals Bleomycin Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Mitomycin Leucovorin Tegafur Antineoplastic Agents, Alkylating Camptothecin Platinum Antineoplastic Agents, Hormonal Antibodies, Monoclonal Tamoxifen Vincristine Contrast Media Gadolinium DTPA Angiogenesis Inhibitors Tumor Suppressor Protein p53 Oxyhemoglobins Nitriles P-Glycoprotein Dacarbazine Mitoxantrone Cytarabine Androgen Antagonists Granulocyte Colony-Stimulating Factor Platinum Compounds Triazoles Technetium Tc 99m Sestamibi Goserelin Receptor, Epidermal Growth Factor Aldehyde Dehydrogenase Flutamide Oxonic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Neoadjuvant Therapy Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Neoplasm Staging Combined Modality Therapy Disease-Free Survival Prognosis Chemoradiotherapy, Adjuvant Survival Rate Survival Analysis Radiotherapy, Adjuvant Cystectomy Esophagectomy Retrospective Studies Mastectomy Follow-Up Studies Prospective Studies Mastectomy, Segmental Lymph Node Excision Chemoradiotherapy Kaplan-Meier Estimate Positron-Emission Tomography Predictive Value of Tests Drug Administration Schedule Multimodal Imaging Ultrasonography, Mammary Hysterectomy Multivariate Analysis Magnetic Resonance Imaging Neoplasm Grading Tomography, X-Ray Computed Preoperative Care Immunohistochemistry Remission Induction Proportional Hazards Models Metastasectomy Gastrectomy Hepatectomy Tumor Burden Clinical Trials as Topic Second-Look Surgery Feasibility Studies Biopsy, Large-Core Needle Randomized Controlled Trials as Topic Radiotherapy Sentinel Lymph Node Biopsy Clinical Trials, Phase II as Topic Radiotherapy Dosage Infusions, Intravenous Sensitivity and Specificity Biopsy, Needle Spectroscopy, Near-Infrared Nomograms Hyperthermia, Induced Induction Chemotherapy Biopsy False Negative Reactions Mammography Radiotherapy, Conformal Patient Selection Statistics, Nonparametric Reproducibility of Results Pneumonectomy Pilot Projects Gene Expression Profiling Radiotherapy, Intensity-Modulated Risk Assessment Risk Factors Salvage Therapy Cohort Studies Physical Examination Treatment Failure Mitotic Index Probability Chi-Square Distribution Chemotherapy, Cancer, Regional Perfusion Diffusion Magnetic Resonance Imaging Infusions, Intra-Arterial Transplantation, Autologous ROC Curve Analysis of Variance Palliative Care Image Interpretation, Computer-Assisted Digestive System Surgical Procedures Clinical Trials, Phase III as Topic In Situ Hybridization, Fluorescence

Phenomena and Processes11

Drug Resistance, Neoplasm Time Factors Sensitivity and Specificity Nomograms Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Premenopause Genes, erbB-2 Probability Chi-Square Distribution Apoptosis

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science4

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Image Interpretation, Computer-Assisted

Health Care32

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Predictive Value of Tests Multivariate Analysis Preoperative Care Proportional Hazards Models Clinical Trials as Topic Feasibility Studies Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Sensitivity and Specificity Nomograms Patient Selection Statistics, Nonparametric Reproducibility of Results Pilot Projects Risk Assessment Risk Factors Cohort Studies Treatment Failure Probability Chi-Square Distribution ROC Curve Analysis of Variance Palliative Care Clinical Trials, Phase III as Topic

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Neoadjuvant Therapy Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Treatment Outcome Neoplasm Staging Doxorubicin Combined Modality Therapy Cisplatin Taxoids Cyclophosphamide Disease-Free Survival Epirubicin Anthracyclines Fluorouracil Antineoplastic Agents Prognosis Paclitaxel Chemoradiotherapy, Adjuvant Osteosarcoma Survival Rate Survival Analysis Neoplasm Recurrence, Local Receptor, erbB-2 Radiotherapy, Adjuvant Cystectomy Neoplasm, Residual Carcinoma, Ductal, Breast Bridged Compounds Esophagectomy Biomarkers, Pharmacological Methotrexate Lymphatic Metastasis Carcinoma, Lobular Adenocarcinoma Receptors, Estrogen Vinblastine Deoxycytidine Esophageal Neoplasms Receptors, Progesterone Retrospective Studies Bone Neoplasms Tumor Markers, Biological Mastectomy Follow-Up Studies Axilla Rectal Neoplasms Ifosfamide Carboplatin Prospective Studies Mastectomy, Segmental Muscle Neoplasms Lymph Node Excision Chemoradiotherapy Kaplan-Meier Estimate Positron-Emission Tomography Fluorodeoxyglucose F18 Carcinoma, Squamous Cell Predictive Value of Tests Organoplatinum Compounds Drug Administration Schedule Multimodal Imaging Ultrasonography, Mammary Urinary Bladder Neoplasms Antibodies, Monoclonal, Humanized Carcinoma Etoposide Stomach Neoplasms Hysterectomy Multivariate Analysis Ki-67 Antigen Lung Neoplasms Drug Resistance, Neoplasm Radiopharmaceuticals Bleomycin Magnetic Resonance Imaging Neoplasm Grading Tomography, X-Ray Computed Antimetabolites, Antineoplastic Nasopharyngeal Neoplasms Carcinoma, Transitional Cell Antineoplastic Agents, Phytogenic Preoperative Care Immunohistochemistry Sarcoma Remission Induction Time Factors Neoplasm Invasiveness Ureteral Neoplasms Ovarian Neoplasms Proportional Hazards Models Metastasectomy Uterine Cervical Neoplasms Liver Neoplasms Gastrectomy Hepatectomy Antibiotics, Antineoplastic Tumor Burden Mitomycin Colorectal Neoplasms

No FAQ available that match "neoadjuvant chemotherapy in patients"